The incidence of HCC attributed to a nonviral etiology (mainly NAFLD) is rising [29,30]; in addition, it is associated with a decline in the percentage of patients with elevated AFP levels. This evidence concerns the gene AFP and metabolic dysfunction-associated steatotic liver disease.